PhRMA Baseline For Rx Costs: 7% Of Health Care Spending Is On Brands
Executive Summary
Brand name drugs account for 7% of health care spending, Pharmaceutical Research & Manufacturers of America President Alan Holmer said during The Economist's Annual Pharmaceutical Roundtable in Philadelphia Nov. 19
You may also be interested in...
Foreign Generic Drug Use Is Key To Rx Price Equity, FDA’s McClellan Says
Foreign countries could redirect billions of dollars into medical innovation by encouraging generic drug use, FDA Commissioner McClellan suggested in a speech to the Drug Information Association in Ottawa, Canada Nov. 18
PhRMA Priorities After Medicare Rx: “Access And Affordability”
The Pharmaceutical Research & Manufacturers of America is adding "affordability" to "access" as a key theme of its advocacy agenda
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011